Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001520642-15-000001
Filing Date
2015-10-14
Accepted
2015-10-14 14:36:38
Documents
1
Effectiveness Date
2015-10-14
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 11120
  Complete submission text file 0001520642-15-000001.txt   12230
Mailing Address 6251 GREENWOOD PLAZA BOULEVARD SUITE 101 GREENWOOD VILLAGE CO 80111
Business Address 6251 GREENWOOD PLAZA BOULEVARD SUITE 101 GREENWOOD VILLAGE CO 80111 720-266-4524
Silvergate Pharmaceuticals, Inc. (Filer) CIK: 0001520642 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-249352 | Film No.: 151158086